2026: Hypertension
This Program will provide an up-to-date review of the current state of the science in hypertension, with a focus on how advances across disciplines can be translated into clinical practice and public policy. Designed for trainees, clinicians, and researchers, the session brings together leading experts in epidemiology, primary care, cardiology, psychosocial and behavioral science, sleep and physical activity, medication adherence, and both pharmacologic and non-pharmacologic treatment.
Across the Program, speakers will highlight how these domains intersect – illustrating key synergies that inform prevention, treatment, and policy – and will conclude with a synthesis of cross-cutting insights and future directions for the field.
Purchase Hypertension Program Recording Here
2024: Diabetes
Join us for a fascinating webinar that explores the evolution of diabetes care, the integration of person-reported aspects of diabetes management, and the complexities of how clinical outcomes are intimately tied to how the person living with diabetes reacts to and implements treatment recommendations.
Leading experts Professor David Marrero and Professor Katharine Barnard-Kelly introduce world-class speakers to tackle different areas of this evolution and discuss their thoughts on gaps in current knowledge, the future research and clinical agenda, and the potential for interdisciplinary collaboration.
Purchase Diabetes Program Recording Here
2023: Asthma
Asthma is a chronic respiratory disease that affects close to 350 million people worldwide. As one of Franz Alexander’s “Holy Seven” psychosomatic diseases, it has confounded medical and psychological scientists for a long time. Biomedical research has made strides in recent decades, highlighting roles of airway hyperreactivity, T-helper cell-driven inflammation, epithelial damage, and remodeling of the airways as major factors in the course of the disease. At the same time, research from a psychobiological angle has identified major roles of socioeconomic, behavioral, and experiential factors in the etiology, pathophysiology, and management of asthma, with ongoing efforts to delineate mechanistic pathways that underlie such associations.
This symposium will bring together biomedical and psychosomatic expertise to review the state of current knowledge on asthma in these areas of inquiry, with the goal to stimulate further cross-disciplinary dialogue and synthesis of ideas, and thereby develop an agenda for both future collaborative research and clinical intervention.
